Martingale Asset Management L P Entrada Therapeutics, Inc. Transaction History
Martingale Asset Management L P
- $4.27 Billion
- Q3 2024
A detailed history of Martingale Asset Management L P transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Martingale Asset Management L P holds 37,923 shares of TRDA stock, worth $672,754. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37,923
Previous 27,697
36.92%
Holding current value
$672,754
Previous $394,000
53.81%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding TRDA
# of Institutions
101Shares Held
28.1MCall Options Held
34.5KPut Options Held
16.4K-
Baker Bros. Advisors LP New York, NY4.87MShares$86.3 Million0.83% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.43MShares$78.5 Million48.7% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$78.2 Million28.09% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.05MShares$54.1 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.71MShares$30.4 Million0.01% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $556M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...